The Times Real Estate

.

Grand Pharma’s Innovative Product for Liver Tumors, Y-90, Is Commercialized in Mainland China, Empowering "Nuclear Power" to The Company’s Performance

  • Written by Auzzi Shopping
HONG KONG SAR - Media OutReach - 20 June 2022 - On 19 June, the technology innovation pharmaceutical company, Grand Pharmaceutical Group Limited (stock code: 0512.HK)’s global innovative product, SIR-Spheres® Y-90 microsphere injection for the treatment of liver malignant tumors, was officially commercialized in Mainland China.

More Articles ...

  1. Babel Finance Raises $80 Million in a Series B funding round, Valuation Hits $2 Billion
  2. Teledyne e2v: Boost dynamic performance of a broadband ADC by some 10 dBFS instantly with spur reduction IP
  3. Choco Up launches Choco Payment powered by Stripe to supercharge growth for digital merchants
  4. Map My Gene Introduces Inborn Talent Gene Test For Kids
  5. Qashier powers GastroBeats with cashless solutions
  6. Cove Rolls Out Exclusive Platform to Track Property Portfolio with Real-time Data for Its Landlords in Singapore
  7. Epicor Speeds Digital Transformation with New Epicor Automation Studio
  8. 8V.com, the World’s First Metaverse Crypto Exchange, is expanding globally and running free airdrops events in June
  9. Citi-HKCSS Community Intern Program in its 12th year of nurturing University Students’ Corporate Social Responsibility
  10. OmniFoods Introduces OmniPork and OmniSeafood to Canada Embracing the plant-based dining trend with restaurant collaborations

Notice: Undefined offset: 1 in /httpdocs/templates/gk_university/html/pagination.php on line 18

Notice: Undefined offset: 1 in /httpdocs/templates/gk_university/html/pagination.php on line 34

Notice: Undefined offset: 2 in /httpdocs/templates/gk_university/html/pagination.php on line 34

Notice: Undefined offset: 3 in /httpdocs/templates/gk_university/html/pagination.php on line 34